Compare XYF & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XYF | FOCL |
|---|---|---|
| Founded | 2014 | 1979 |
| Country | China | France |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.1M | 206.3M |
| IPO Year | 2018 | 1998 |
| Metric | XYF | FOCL |
|---|---|---|
| Price | $4.82 | $4.21 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $8.80 |
| AVG Volume (30 Days) | 48.4K | ★ 62.3K |
| Earning Date | 11-19-2026 | 11-05-2026 |
| Dividend Yield | ★ 11.63% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $34.10 |
| P/E Ratio | $0.90 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $3.30 | $3.97 |
| 52 Week High | $13.16 | $6.40 |
| Indicator | XYF | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 47.00 |
| Support Level | $4.62 | $4.01 |
| Resistance Level | $5.15 | $4.50 |
| Average True Range (ATR) | 0.21 | 0.24 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 21.25 | 43.14 |
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.